What is the ChartMill fundamental rating of INHIBIKASE THERAPEUTICS INC (IKT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to IKT.
Can you provide the valuation status for INHIBIKASE THERAPEUTICS INC?
ChartMill assigns a valuation rating of 1 / 10 to INHIBIKASE THERAPEUTICS INC (IKT). This can be considered as Overvalued.
What is the profitability of IKT stock?
INHIBIKASE THERAPEUTICS INC (IKT) has a profitability rating of 1 / 10.
Can you provide the financial health for IKT stock?
The financial health rating of INHIBIKASE THERAPEUTICS INC (IKT) is 8 / 10.